<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Fri, 17 Apr 2026 13:00:28 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/sparktx/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[I was wrong about Zogenix!!!]]></title><description><![CDATA[Note: I meant to say that sub-1% factor activity is SEVERE hemophilia. Normal is from 50% to 150%. Today I talk again about Zogenix because I was wrong about Study 2 being priced in! Congrats to the ZGNX]]></description><link>http://direct.ecency.com/biotechnology/@talkchain/i-was-wrong-about-zogenix</link><guid isPermaLink="true">http://direct.ecency.com/biotechnology/@talkchain/i-was-wrong-about-zogenix</guid><category><![CDATA[biotechnology]]></category><dc:creator><![CDATA[talkchain]]></dc:creator><pubDate>Sat, 14 Jul 2018 21:29:42 GMT</pubDate><enclosure url="https://images.ecency.com/p/S5Eokt4BcQdk7EHeT1aYjzebg2hC7hkthT45e5W7YfkCMguTUDpFe1A5KXzx93aquFUbMXC?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>